(NIH) Attachment FDA, U43 Phase I. applications. AHRQ, VA N N Incl : Incl: Incl: Required for Phase II, The Commercialization E NIH, V 1.1 Plan R42, UT2, R44, Direct Phase II and Plan is required for CDC, (NIH) Attachment U44, SB1, UB1 Fast Track Phase II and Fast FDA, submissions Track submissions. AHRQ, VA N N Incl : Incl: Incl: Limited to 12 pages The Commercialization E NIH, V 1.1 Plan R42, UT2, R44, Plan is limited to CDC, (NIH) Attachment U44, SB1,UB1 twelve (12) pages. FDA, AHRQ, VA Question 8. 023.14 Receipt of (NIH) Phase II SBIR Awards (Y/N) Company 023.15 (NIH) History Attachment Question 9. 023.16 SBIR PD/PI (NIH) Primary Employment (Y/N)
(NIH) Attachment FDA, AHRQ, VA U43 Phase I. applications. (NIH) Plan Attachment N N Incl : NIH, CDC, FDA, AHRQ, VA Incl: V 1.1 Incl: R42, UT2, R44, U44, SB1, UB1 Required for Phase II, Direct Phase II and Fast Track submissions The Commercialization Plan is required for Phase II and Fast Track submissions. E (NIH) Plan Attachment N N Incl : NIH, CDC, FDA, AHRQ, VA Incl: V 1.1 Incl: R42, UT2, R44, U44, SB1,UB1 Limited to 12 pages The Commercialization Plan is limited to twelve (12) pages. E (NIH) Question 8. Receipt of Phase II SBIR Awards (Y/N) 023.14 (NIH) Company History Attachment 023.15 (NIH) Question 9. SBIR PD/PI Primary Employment (Y/N) 023.16
eSub-validations-draft-2-5-2016.docx